Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. - Sillesen,H.; Amarenco,P.; Hennerici,M.G. (Stroke, 2008)